Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 192

The DOI matches its Crossref record.

Allergic diseases and asthma: a major global health concern

Pawankar, Ruby, Canonica, Giorgio W., Holgate, Stephen T., Lockey, Richard F. · 2012 · Current Opinion in Allergy & Clinical Immunology

Abstract

The prevalence of allergic diseases and asthma is increasing worldwide, particularly in low and middle-income countries. Moreover, the complexity and severity of allergic diseases, including asthma, continue to increase especially in children and young adults, who are bearing the greatest burden of these trends. In order to address this major global challenge that threatens health and economies alike, it is important to have a global action plan that includes partnerships involving different stakeholders from low-income, middle-income, and high-income countries. Allergic diseases include life-threatening anaphylaxis, food allergies, certain forms of asthma, rhinitis, conjunctivitis, angioedema, urticaria, eczema, eosinophilic disorders, including eosinophilic esophagitis, and drug and insect allergies. Globally, 300 million people suffer from asthma and about 200–250 million people suffer from food allergies [1]. One-tenth of the population suffers from drug allergies and 400 million from rhinitis [1]. Moreover, allergic diseases commonly occur together in the same individual, one disease with the other. This requires an integrated approach to diagnosis and treatment and greater awareness of the underlying causes among family physicians, patients as well as specialists. A recent report from the World Allergy Organization, the WAO White Book on Allergy[1], summarizes the burden of allergic diseases worldwide, the risk factors, impact on quality of life of patients, morbidity, mortality, their socio-economic consequences, recommended treatment strategies, future therapies, and the cost–benefit analyses of care services. For instance, asthma prevalence is rising in several high as well as low-income and middle-income countries, and the prevalence and impact of allergic diseases continue to grow. According to the World Health Organization, the number of patients having asthma is 300 million and with the rising trends it is expected to increase to 400 million by 2025. Patients with asthma and allergic diseases have a reduced quality of life. According to the World Health Organization, asthma causes 250 000 deaths annually. Moreover, asthma in infancy often goes unrecognized and thus untreated. In the United States, 23 million people including 7 million children suffer from asthma and the prevalence is increasing. The economic costs of asthma are high both in terms of direct and indirect costs [1] (Table 1), especially in severe or uncontrolled asthma. In the United States, pediatric asthma results in 14 million missed days of school each year, which in turn result in lost workdays – and lost wages – for caregivers [2]. As asthma continues to affect more children in lower-income countries, this will lead to long-term consequences for their education and perpetuation of their poverty. We need to find ways to control indoor and outdoor air pollution, to train healthcare professionals to diagnose and treat asthma in children, and to ensure that asthma medications are affordable for all who need them. Educational programs for self-management of asthma and national efforts to tackle asthma as a public health problem have produced remarkable benefits resulting in dramatic reductions in deaths and hospital admissions [1,3].Table 1: The economic burden of allergyThe upsurge in the prevalence of allergies is observed as societies become more affluent and urbanized. An increase in environmental risk factors like outdoor and indoor pollution like tobacco smoke combined with reduced biodiversity also contributes to this rise in prevalence. In many low-income and middle-income countries, including rural areas in India, people rely on solid fuel (wood, cow dung, or crop residues) that they burn in simple stoves or open fires for domestic energy [1]. Secondhand smoke has become more common as parents become affluent enough to buy cigarettes. Together, these factors generate indoor air pollution that is estimated to be as much as five times as severe in poor countries as in rich ones [4]. In rural Bangladesh, the prevalence of wheezing in rural children over a 12-month period was 16% [5]. The White Book highlights data from China that reports outdoor pollution as a cause of 300 000 deaths annually [1]. Moreover, climate change, change in ambient temperatures, and changes in weather during pollen seasons can cause both biological and chemical changes to pollens and have direct adverse consequences on human health by inducing disease exacerbations especially in urban and polluted regions. Appropriate environmental control measures of risk factors like indoor tobacco smoke, outdoor pollution, and biomass fuel can have huge health benefits. There are also other complex, but measurable, associations between early life circumstances like maternal and childhood nutrition. Such evidences indicate early life opportunities for interventions targeted towards the prevention of allergies and asthma. Persons with allergic diseases like asthma

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/aci.0b013e32834ec13b

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 192

Metadata

Authors
Pawankar, R., Canonica, G. W., Holgate, S. T., & Lockey, R. F.
Venue
Current Opinion in Allergy & Clinical Immunology
Published
2012-02
Volume
12
Issue
1
Pages
39-41
ISSN
  • 1473-6322 (ISSN-L)
  • 1528-4050
OpenAlex
W2092247531
Cited by
192
References
0
FWCI
5.97
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Allergic diseases and asthma: a major global health concern. https://app.cochat.ai/papers/10.1097/aci.0b013e32834ec13b
The paper
Pawankar, R., Canonica, G. W., Holgate, S. T., & Lockey, R. F. (2012). Allergic diseases and asthma: a major global health concern. Current Opinion in Allergy & Clinical Immunology. https://doi.org/10.1097/aci.0b013e32834ec13b

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.